Physician profile
Sunil H Patel
NPI 1588721658
$1,098.48
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $234 · 2020: $131 · 2021: $219 · 2022: $91.47 · 2023: $112 · 2024: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $422.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $233.70 | 2024 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $140.09 | 2019-2021 | |
| Abbvie INC. | $120.97 | 2019-2024 | |
| Janssen Biotech, INC. | $83.81 | 2023-2024 | Stelara |
| Alnylam Pharmaceuticals INC. | $75.23 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $72.50 | 2019-2021 | |
| Gilead Sciences, INC. | $71.07 | 2019-2021 | |
| Allergan, INC. | $64.06 | 2020 | |
| Lilly USA, LLC | $55.56 | 2022-2023 | Mounjaro |
| Astrazeneca Pharmaceuticals LP | $54.63 | 2021-2022 | |
| Olympus America INC. | $27.80 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.00 | 2019 | |
| Corium, LLC | $20.49 | 2023 | Azstarys |
| Qol Medical, LLC | $15.00 | 2022 | |
| Ironshore Pharmaceuticals INC. | $14.87 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $14.43 | 2023 | Rexulti |
| Almatica Pharma LLC | $13.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.